PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Ginges Center of Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.\', \'Pediatric Neurology Unit, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.\', \'Epilepsy and EEG Unit, Neurology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\', \'Sackler Faculty of Medicine ,Tel Aviv University, Tel Aviv, Israel.\', \'Department of Neurology, Rambam Health Care Campus and Technion Faculty of Medicine, Haifa, Israel.\', \'Pediatric Epilepsy and Neurology Service, Barzilai Medical Center, Ashkelon, Israel.\', \'Pediatric Neurology Unit, Safra Pediatric Hospital, Sheba Medical Center, Tel Hashomer, Israel.\', \'Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • The Israel Medical Association journal : IMAJ
is ?:pmid of
?:pmid
?:pmid
  • 33249784
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Treating Epilepsy Patients with Investigational Anti-COVID-19 Drugs: Recommendations by the Israeli Chapter of the ILAE.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all